<unk>  (brand names: Serdolect, and Serlect) is an antipsychotic medication.<unk>  was developed by the Danish pharmaceutical company H. Lundbeck and marketed under license by Abbott Labs. Like other atypical antipsychotics, it has activity at dopamine and serotonin receptors in the brain. It is used in the treatment of schizophrenia. It is classified chemically as a phenylindole derivative.<unk>  is not approved for use in the United States.
Sertindole
Iprindole
Butriptyline
Ketobemidone
Diphenidol
Bromocriptine
Aglepristone
Haloperidol 